The association between the presence of polymorphisms rs1801320 and rs1801321 of RAD51, rs10483813 and rs3784099 of RAD51B, rs3218536 of XRCC2, and rs861539 of XRCC3 and the risk of prostate cancer was examined. Here, XRCC3 is linked to prostate cancer.